We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Vijay Mallya controlled UB Group has sold the Tumkur manufacturing facility
of its subsidiary UB Pharmaceuticals Ltd (UBPL) to Bangalore-based Bayir Chemicals.
ALDA Pharmaceuticals has filed an additional national patent application in
the European Union (EU) for the formulation and production of its infection
control technology.
Drugmaker AEterna Zentaris Inc. said its Impavido
treatment for the skin-affecting form of the disease leishmaniasis has been
approved by the Colombian Food and Drug Agency.
Despite fierce resistance from NGOs and leftist political parties,
India's government has secured final approval for its amendment to the country's
Patent Ordinance.
Shionogi said that it will increase its R&D spending by 10 percent each
year for the next five years, to help accelerate its new prescription drug development,
as reported in Morningstar.